U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. Overview: Clinical Pharmacology Considerations for Food Effect Studies - 06/15/2023
  1. News & Events for Human Drugs

Virtual

Event Title
Overview: Clinical Pharmacology Considerations for Food Effect Studies
June 15, 2023


Date:
June 15, 2023
Time:
1:00 PM - 2:00 PM ET

Topic & Presentation

Speakers

Overview: Clinical Pharmacology Considerations for Food Effect Studies

 

Clinical Pharmacology Considerations for Food Effect Studies: An Overview of the FDA Food Effect Guidance.pdf

Vikram Arya, Ph.D., FCP
Associate Director for Therapeutic Review
Division of Infectious Disease Pharmacology
Office of Clinical Pharmacology | CDER | FDA

Q&A Discussion Panel

Vikram Arya

and

Brian Booth, Ph.D.
Director
Division of Cancer Pharmacology I
Office of Clinical Pharmacology | CDER | FDA

Ethan Stier, Ph.D.
Associate Director for Lifecycle Management
Immediate Office | Office of Clinical Pharmacology | CDER | FDA

 

Visit CDER Small Business and Industry Assistance Page

ABOUT THIS WEBINAR

In this webinar, FDA will discuss:

  • Importance of assessing the effect of food on drugs and reasons for issuing the final guidance
  • Timing of conducting food effect studies during drug development
  • General considerations for designing food effect studies
  • Other considerations related to assessing the effect of food on a drug

TOPICS COVERED

  • Timing of conducting food effect studies during drug development
  • Type of meals to be evaluated
  • General considerations for designing food effect studies

LEARNING OBJECTIVES

  • Understand the importance of assessing the effect of food on drugs
  • Comprehend general considerations for designing food effect studies
  • Discuss data analysis considerations related to food effect assessment

INTENDED AUDIENCE

  • Drug development scientists involved with food effect studies conducted to support regulatory submissions
  • Scientists assessing food effect studies submitted as part of regulatory submissions
  • Foreign regulators and policy makers

FDA RESOURCES

Back to Top